Development of a novel enzyme/prodrug combination for gene therapy of cancer: horseradish peroxidase/indole-3-acetic acid

Citation
O. Greco et al., Development of a novel enzyme/prodrug combination for gene therapy of cancer: horseradish peroxidase/indole-3-acetic acid, CANC GENE T, 7(11), 2000, pp. 1414-1420
Citations number
25
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
CANCER GENE THERAPY
ISSN journal
09291903 → ACNP
Volume
7
Issue
11
Year of publication
2000
Pages
1414 - 1420
Database
ISI
SICI code
0929-1903(200011)7:11<1414:DOANEC>2.0.ZU;2-E
Abstract
This paper demonstrates the potential for utilizing the plant enzyme, horse radish peroxidase (HRP), in a gene-directed enzyme prodrug therapy context. Human T24 bladder carcinoma cells transfected with a mammalian expression vector containing the HRP cDNA were selectively sensitized to the nontoxic plant hormone, indole-3-acetic acid (IAA). The HRP/IAA-induced cell kill wa s effective in normoxic and anoxic conditions. The activated drug is a long -lived species able to cross cell membranes, and cell contact appears not t o be required for a bystander effect to take place. These preliminary resul ts suggest that the delivery of the HRP gene to human tumors followed by IA A treatment may provide a novel cancer gene-directed enzyme prodrug therapy approach, with potential to target hypoxic cells.